학술논문
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial
Document Type
Article
Author
Source
In: International Journal of Gynecological Cancer . (International Journal of Gynecological Cancer, 1 April 2021, 31(4):617-622)
Subject
Language
English
ISSN
15251438
1048891X
1048891X